Erratum: Systems biology for molecular life sciences and its impact in biomedicine (Cellular and Molecular Life Sciences DOI 10.1007/s00018-012-1109-z);Systems biology for molecular life sciences and its impact in biomedicine

Cellular and Molecular Life Sciences

Volumn 70, Issue 6, 2013, Pages 1035-1053

  Medina, Miguel Ángel ^a,b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

Complexity; Disease ome; Holism; Network; Reductionism; Systems biology

Indexed keywords

ACCESS TO INFORMATION; BIOINFORMATICS; BIOMEDICINE; CANCER RESEARCH; ESSENTIAL GENE; FACTUAL DATABASE; GENE INTERACTION; GENE MUTATION; GENOTYPE; HISTORY OF MEDICINE; HUMAN; HUMAN GENOME PROJECT; METAPHYSICS; MOLECULAR MEDICINE; NONHUMAN; PERSONALIZED MEDICINE; PHARMACOLOGICAL SCIENCE; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; SCIENTIFIC LITERATURE; SYSTEMS BIOLOGY; SYSTEMS THEORY;

EID: 84875232161     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1366-5     Document Type: Erratum

References (143)

1. Chuang HY, Hofree M, Ideker T (2010) A decade of systems biology. Annu Rev Cell Dev Biol 26:721-744
2. Loeb J (1912) The mechanistic conception of life. Bellknap Press, Cambridge
3. Smuts JC (1926) Holism and evolution. Viking Press, New York
4. Corning P (2002) The re-emergence of "emergence". A venerable concept in search of a theory. Complexity 7:18-30 (Pubitemid 36092755)
5. Vernadsky V (1926) The Biosphere [in Russian]. Nauch, St. Petersburg
6. Williams RJ (1956) Biochemical Individuality: the Key for the Genotrophic Concept. Wiley, New York
7. La Jacob F (1970) Logique du Vivant. Gallimard, Paris
8. Polanyi M (1968) Life's irreducible structure. Live mechanisms and information in DNA are boundary conditions with a sequence of boundaries above them. Science 160:1308-1312
9. Von Bertalanffy L (1950) The theory of open systems in physics and biology. Science 111:23-29
10. Von Bertalanffy L (1968) General systems theory: foundations, development, applications. George Braziller, New York
11. Kitano H (2002) Systems biology: a brief overview. Science 295:1662-1664 (Pubitemid 34202893)
12. Hartwell LH, Hopfield JJ, Leibler S, Murray AW (1999) From molecular to modular cell biology. Nature 402:C47-C52
13. Ideker T, Galitski T, Hood L (2001) A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet 2:343-372 (Pubitemid 35265011)
14. Ranea JA, Morilla I, Lees JG, Reid AJ, Yeats C, Clegg AB, Sánchez-Jiménez F, Orengo C (2010) Finding the "dark matter" in human and yeast protein network prediction and modelling. PLoS Comput Biol 6:e1000945
15. Barabasi AL (2002) Linked: the new science of networks. Basic Books, New York
16. Jeong H, Tombor B, Albert R, Oltvai ZN, Barabasi AL (2000) The large-scale organization of metabolic networks. Nature 407:651-654
17. Rodríguez-Caso C, Medina MA, Solé RV (2005) Topology, tinkering and evolution of the human transcription factor network. FEBS J 272:6423-6434 (Pubitemid 41815629)
18. Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, Zhang LV, Dupuy D, Walhout AJ, Cusick ME, Roth FP, Vidal M (2004) Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 430:88-93 (Pubitemid 38915230)
19. Watts DJ, Strogatz SH (1998) Collective dynamics of 'small-world' networks. Nature 393:440-442 (Pubitemid 28292183)
20. Li S, Armstrong CM, Bertin N, Ge H, Milstein S, Boxem M, Vidalain PO, Han JD, Chesneau A, Hao T, Goldberg DS, Li N, Martinez M, Rual JF, Lamesch P, Xu L, Tewari M, Wong SL, Zhang LV, Berriz GF, Jacotot L, Vaglio P, Reboul J, Hirozane-Kishikawa T, Li Q, Gabel HW, Elewa A, Baumgartner B, Rose DJ, Yu H, Bosak S, Sequerra R, Fraser A, Mango SE, Saxton WM, Strome S, Van Den Heuvel S, Piano F, Vandenhaute J, Sardet C, Gerstein M, Doucette-Stamm L, Gunsalus KC, Harper JW, Cusick ME, Roth FP, Hill DE, Vidal M (2004) A map of the interactome network of the metazoan C. elegans. Science 303:540-543 (Pubitemid 38120855)
21. Cusick ME, Klitgord N, Vidal M, Hill DE (2005) Interactome: gateway into systems biology. Hum Mol Genet 14 Spec No. 2:R171-181 (Pubitemid 41631885)
22. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, Timm J, Mintzlaff S, Abraham C, Bock N, Kietzmann S, Goedde A, Toksoz E, Droege A, Krobitsch S, Korn B, Birchmeier W, Lehrach H, Wanker EE (2005) A human protein-protein interaction network: a resource for annotating the proteome. Cell 122:957-968 (Pubitemid 41345212)
23. Warner GJ, Adeleye YA, Ideker T (2006) Interactome networks: the state of the science. Genome Biol 7:301
24. Figeys D (2008) Mapping the human protein interactome. Cell Res 18:716-724 (Pubitemid 351948229)
25. Venkatesan K, Rual JF, Vazquez A, Stelzl U, Lemmens I, Hirozane-Kishikawa T, Hao T, Zenkner M, Xin X, Goh KI, Yildirim MA, Simonis N, Heinzmann K, Gebreab F, Sahalie JM, Cevik S, Simon C, de Smet AS, Dann E, Smolyar A, Vinayagam A, Yu H, Szeto D, Borick H, Dricot A, Klitgord N, Murray RR, Lin C, Lalowski M, Timm J, Rau K, Boone C, Braun P, Cusick ME, Roth FP, Hill DE, Tavernier J, Wanker EE, Barabasi AL, Vidal M (2009) An empirical framework for binary interactome mapping. Nat Methods 6:83-90
26. Walhout AJ, Reboul J, Shtanko O, Bertin N, Vaglio P, Ge H, Lee H, Doucette-Stamm L, Gunsalus KC, Schetter AJ, Morton DG, Kemphues KJ, Reinke V, Kim SK, Piano F, Vidal M (2002) Integrating interactome, phenome, and transcriptome mapping data for the C. elegans germline. Curr Biol 12:1952-1958 (Pubitemid 35426710)
27. Lage K, Karlberg EO, Storling ZM, Olason PI, Pedersen AG, Rigina O, Hinsby AM, Tumer Z, Pociot F, Tommerup N, Moreau Y, Brunak S (2007) A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol 25:309-316 (Pubitemid 46402863)
28. Yao C, Li H, Zhou C, Zhang L, Zou J, Guo Z (2010) Multi-level reproducibility of signature hubs in human interactome for breast cancer metastasis. BMC Syst Biol 4:151
29. Shutt TE, Shadel GS (2007) Expanding the mitochondrial interactome. Genome Biol 8:203
30. Reja R, Venkatakrishnan AJ, Lee J, Kim BC, Ryu JW, Gong S, Bhak J, Park D (2009) MitoInteractome: mitochondrial protein interactome database, and its application in 'aging network' analysis. BMC Genomics 10(Suppl 3):S20
31. Bandyopadhyay S, Chiang CY, Srivastava J, Gersten M, White S, Bell R, Kurschner C, Martin CH, Smoot M, Sahasrabudhe S, Barber DL, Chanda SK, Ideker T (2010) A human MAP kinase interactome. Nat Methods 7:801-805
32. Eden G, Archinti M, Furlan F, Murphy R, Degryse B (2011) The urokinase receptor interactome. Curr Pharm Des 17:1874-1889
33. Tieri P, Termanini A, Bellavista E, Salvioli S, Capri M, Franceschi C (2012) Charting the NF-kappaB pathway interactome map. PLoS ONE 7:e32678
34. Tarassov K, Messier V, Landry CR, Radinovic S, Serna Molina MM, Shames I, Malitskaya Y, Vogel J, Bussey H, Michnick SW (2008) An in vivo map of the yeast protein interactome. Science 320:1465-1470 (Pubitemid 351929421)
35. Kast J (2008) Making connections for life: an in vivo map of the yeast interactome. HFSP J 2:244-250
36. Przytycka TM, Singh M, Slonim DK (2010) Toward the dynamic interactome: it's about time. Brief Bioinform 11:15-29
37. Gallego O, Betts MJ, Gvozdenovic-Jeremic J, Maeda K, Matetzki C, Aguilar-Gurrieri C, Beltran-Alvarez P, Bonn S, Fernandez-Tornero C, Jensen LJ, Kuhn M, Trott J, Rybin V, Muller CW, Bork P, Kaksonen M, Russell RB, Gavin AC (2010) A systematic screen for protein-lipid interactions in Saccharomyces cerevisiae. Mol Syst Biol 6:430
38. Kohler S, Bauer S, Horn D, Robinson PN (2008) Walking the interactome for prioritization of candidate disease genes. Am J Hum Genet 82:949-958
39. Coulombe B (2011) Mapping the disease protein interactome: toward a molecular medicine GPS to accelerate drug and biomarker discovery. J Proteome Res 10:120-125
40. Kahle JJ, Gulbahce N, Shaw CA, Lim J, Hill DE, Barabasi AL, Zoghbi HY (2011) Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia. Hum Mol Genet 20:510-527
41. Soler-Lopez M, Zanzoni A, Lluis R, Stelzl U, Aloy P (2011) Interactome mapping suggests new mechanistic details underlying Alzheimer's disease. Genome Res 21:364-376
42. Vidal M, Cusick ME, Barabasi AL (2011) Interactome networks and human disease. Cell 144:986-998
43. Simonis N, Rual JF, Lemmens I, Boxus M, Hirozane-Kishikawa T, Gatot JS, Dricot A, Hao T, Vertommen D, Legros S, Daakour S, Klitgord N, Martin M, Willaert JF, Dequiedt F, Navratil V, Cusick ME, Burny A, Van Lint C, Hill DE, Tavernier J, Kettmann R, Vidal M, Twizere JC (2012) Host-pathogen interactome mapping for HTLV-1 and 2 retroviruses. Retrovirology 9:26
44. Hernandez-Toro J, Prieto C, De las Rivas J (2007) APID2NET: unified interactome graphic analyzer. Bioinformatics 23:2495-2497 (Pubitemid 47423852)
45. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, Christmas R, Avila-Campilo I, Creech M, Gross B, Hanspers K, Isserlin R, Kelley R, Killcoyne S, Lotia S, Maere S, Morris J, Ono K, Pavlovic V, Pico AR, Vailaya A, Wang PL, Adler A, Conklin BR, Hood L, Kuiper M, Sander C, Schmulevich I, Schwikowski B, Warner GJ, Ideker T, Bader GD (2007) Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2:2366-2382
46. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27:431-432
47. Montañez R, Sánchez-Jiménez F, Quesada AR, Medina MA (2011) Exploring and challenging the network of angiogenesis. Sci Rep 1:61
48. Kravchenko-Balasha N, Levitzki A, Goldstein A, Rotter V, Gross A, Remacle F, Levine RD (2012) On a fundamental structure of gene networks in living cells. Proc Natl Acad Sci USA 109:4702-4707
49. Westerhoff HV, Winder C, Messiha H, Simeonidis E, Adamczyk M, Verma M, Bruggeman FJ, Dunn W (2009) Systems biology: the elements and principles of life. FEBS Lett 583:3882-3890
50. Wilson EO (1999) Consilience: the Unity of Knowledge. Vintage Books, New York
51. (1999) Consilience, complexity, and communication: three challenges at the start of the new century. Bioessays 21:983-984
52. Rodríguez-Caso C, Montañez R, Cascante M, Sánchez-Jiménez F, Medina MA (2006) Mathematical modeling of polyamine metabolism in mammals. J Biol Chem 281:21799-21812 (Pubitemid 44181884)
53. Li C, Courtot M, Le Novere N, Laibe C (2010) BioModels.net Web Services, a free and integrated toolkit for computational modelling software. Brief Bioinform 11:270-277
54. Reyes-Palomares A, Montañez R, Sánchez-Jiménez F, Medina MA (2012) A combined model of hepatic polyamine and sulfur amino acid metabolism to analyze S-adenosyl methionine availability. Amino Acids 42:597-610
55. Savageau MA (1969) Biochemical systems analysis. II. The steady-state solutions for an n-pool system using a power-law approximation. J Theor Biol 25:370-379
56. Savageau MA (1969) Biochemical systems analysis. I. Some mathematical properties of the rate law for the component enzymatic reactions. J Theor Biol 25:365-369
57. Savageau MA (1970) Biochemical systems analysis. 3. Dynamic solutions using a power-law approximation. J Theor Biol 26:215-226
58. Voit EO (2000) Computational analysis of biochemical systems. Cambridge University Press, Cambridge
59. Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27-30 (Pubitemid 30047706)
60. Mendes P, Hoops S, Sahle S, Gauges R, Dada J, Kummer U (2009) Computational modeling of biochemical networks using COPASI. Methods Mol Biol 500:17-59
61. Reyes-Palomares A, Montañez R, Real-Chicharro A, Chniber O, Kerzazi A, Navas-Delgado I, Medina MA, Aldana-Montes JF, Sánchez-Jiménez F (2009) Systems biology metabolic modeling assistant: an ontology-based tool for the integration of metabolic data in kinetic modeling. Bioinformatics 25:834-835
62. Cvijovic M, Olivares-Hernandez R, Agren R, Dahr N, Vongsangnak W, Nookaew I, Patil KR, Nielsen J (2010) BioMet Toolbox: genome-wide analysis of metabolism. Nucleic Acids Res 38:W144-W149
63. Schellenberger J, Que R, Fleming RM, Thiele I, Orth JD, Feist AM, Zielinski DC, Bordbar A, Lewis NE, Rahmanian S, Kang J, Hyduke DR, Palsson BO (2011) Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0. Nat Protoc 6:1290-1307
64. Voit EO, Radivoyevitch T (2000) Biochemical systems analysis of genome-wide expression data. Bioinformatics 16:1023-1037 (Pubitemid 32051016)
65. Ma H, Sorokin A, Mazein A, Selkov A, Selkov E, Demin O, Goryanin I (2007) The Edinburgh human metabolic network reconstruction and its functional analysis. Mol Syst Biol 3:135
66. Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, Vo TD, Srivas R, Palsson BO (2007) Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci USA 104:1777-1782 (Pubitemid 46239855)
67. Terzer M, Maynard ND, Covert MW, Stelling J (2009) Genome-scale metabolic networks. Wiley Interdiscip Rev Syst Biol Med 1:285-297
68. Edwards JS, Palsson BO (2000) Metabolic flux balance analysis and the in silico analysis of Escherichia coli K-12 gene deletions. BMC Bioinformatics 1:1
69. Kauffman KJ, Prakash P, Edwards JS (2003) Advances in flux balance analysis. Curr Opin Biotechnol 14:491-496 (Pubitemid 37298033)
70. Lee JM, Gianchandani EP, Papin JA (2006) Flux balance analysis in the era of metabolomics. Brief Bioinform 7:140-150 (Pubitemid 44404880)
71. Raman K, Chandra N (2009) Flux balance analysis of biological systems: applications and challenges. Brief Bioinform 10:435-449
72. Murabito E, Simeonidis E, Smallbone K, Swinton J (2009) Capturing the essence of a metabolic network: a flux balance analysis approach. J Theor Biol 260:445-452
73. Orth JD, Thiele I, Palsson BO (2010) What is flux balance analysis? Nat Biotechnol 28:245-248
74. Gianchandani EP, Chavali AK, Papin JA (2010) The application of flux balance analysis in systems biology. Wiley Interdiscip Rev Syst Biol Med 2:372-382
75. Li Z, Wang RS, Zhang XS (2011) Two-stage flux balance analysis of metabolic networks for drug target identification. BMC Syst Biol 5(Suppl 1):S11
76. Tiger CF, Krause F, Cedersund G, Palmer R, Klipp E, Hohmann S, Kitano H, Krantz M (2012) A framework for mapping, visualisation and automatic model creation of signal-transduction networks. Mol Syst Biol 8:578
77. Wild DJ, Ding Y, Sheth AP, Harland L, Gifford EM, Lajiness MS (2012) Systems chemical biology and the Semantic Web: what they mean for the future of drug discovery research. Drug Discov Today 17:469-474
78. Ekins S, Nikolsky Y, Nikolskaya T (2005) Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity. Trends Pharmacol Sci 26:202-209 (Pubitemid 40432655)
79. Hoeng J, Deehan R, Pratt D, Martin F, Sewer A, Thomson TM, Drubin DA, Waters CA, de Graaf D, Peitsch MC (2012) A network-based approach to quantifying the impact of biologically active substances. Drug Discov Today 17:413-418
80. Quesada AR, Muñoz-Chápuli R, Medina MA (2006) Anti-angiogenic drugs: from bench to clinical trials. Med Res Rev 26:483-530 (Pubitemid 43939203)
81. Medina MA, Muñoz-Chápuli R, Quesada AR (2007) Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope. J Cell Mol Med 11:374-382 (Pubitemid 47153451)
82. Quesada AR, Medina MA, Muñoz-Cáapuli R, Ponce AL (2010) Do not say ever never more: the ins and outs of antiangiogenic therapies. Curr Pharm Des 16:3932-3957
83. Quesada AR, Medina MA, Alba E (2007) Playing only one instrument may be not enough: limitations and future of the antiangiogenic treatment of cancer. BioEssays 29:1159-1168 (Pubitemid 350057387)
84. Lehar J, Krueger AS, Avery W, Heilbut AM, Johansen LM, Price ER, Rickles RJ, Short GF 3rd, Staunton JE, Jin X, Lee MS, Zimmermann GR, Borisy AA (2009) Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol 27:659-666
85. Kummar S, Chen HX, Wright J, Holbeck S, Millin MD, Tomaszewski J, Zweibel J, Collins J, Doroshow JH (2010) Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements. Nat Rev Drug Discov 9:843-856
86. Cokol M, Chua HN, Tasan M, Mutlu B, Weinstein ZB, Suzuki Y, Nergiz ME, Costanzo M, Baryshnikova A, Giaever G, Nislow C, Myers CL, Andrews BJ, Boone C, Roth FP (2011) Systematic exploration of synergistic drug pairs. Mol Syst Biol 7:544
87. Wagner H (2011) Synergy research: approaching a new generation of phytopharmaceuticals. Fitoterapia 82:34-37
88. Hopkins AL (2007) Network pharmacology. Nat Biotechnol 25:1110-1111 (Pubitemid 47538107)
89. Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4:682-690
90. Berger SI, Iyengar R (2009) Network analyses in systems pharmacology. Bioinformatics 25:2466-2472
91. Hansen J, Zhao S, Iyengar R (2011) Systems pharmacology of complex diseases. Ann N Y Acad Sci 1245:E1-E5
92. Zhao S, Iyengar R (2012) Systems pharmacology: network analysis to identify multiscale mechanisms of drug action. Annu Rev Pharmacol Toxicol 52:505-521
93. Edelman LB, Eddy JA, Price ND (2010) In silico models of cancer. Wiley Interdiscip Rev Syst Biol Med 2:438-459
94. Abbod MF, Hamdy FC, Linkens DA, Catto JW (2009) Predictive modeling in cancer: where systems biology meets the stock market. Expert Rev Anticancer Ther 9:867-870
95. Deisboeck TS, Zhang L, Yoon J, Costa J (2009) In silico cancer modeling: is it ready for prime time? Nat Clin Pract Oncol 6:34-42
96. Alarcon T, Byrne HM, Maini PK (2004) A mathematical model of the effects of hypoxia on the cell-cycle of normal and cancer cells. J Theor Biol 229:395-411 (Pubitemid 38844943)
97. Spencer SL, Berryman MJ, Garcia JA, Abbott D (2004) An ordinary differential equation model for the multistep transformation to cancer. J Theor Biol 231:515-524 (Pubitemid 39369983)
98. Kohandel M, Sivaloganathan S, Oza A (2006) Mathematical modeling of ovarian cancer treatments: sequencing of surgery and chemotherapy. J Theor Biol 242:62-68 (Pubitemid 44188775)
99. Ostby I, Oyehaug L, Steen HB (2006) A stochastic model of cancer initiation including a bystander effect. J Theor Biol 241:751-764 (Pubitemid 44097025)
100. d'Onofrio A, Tomlinson IP (2007) A nonlinear mathematical model of cell turnover, differentiation and tumorigenesis in the intestinal crypt. J Theor Biol 244:367-374 (Pubitemid 46039822)
101. Verschraegen C, Vinh-Hung V, Cserni G, Gordon R, Royce ME, Vlastos G, Tai P, Storme G (2005) Modeling the effect of tumor size in early breast cancer. Ann Surg 241:309-318
102. Bearer EL, Lowengrub JS, Frieboes HB, Chuang YL, Jin F, Wise SM, Ferrari M, Agus DB, Cristini V (2009) Multiparameter computational modeling of tumor invasion. Cancer Res 69:4493-4501
103. McDougall SR, Anderson AR, Chaplain MA (2006) Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. J Theor Biol 241:564-589 (Pubitemid 44041121)
104. Bauer AL, Jackson TL, Jiang Y (2007) A cell-based model exhibiting branching and anastomosis during tumor-induced angiogenesis. Biophys J 92:3105-3121 (Pubitemid 46684572)
105. Khalil IG, Hill C (2005) Systems biology for cancer. Curr Opin Oncol 17:44-48 (Pubitemid 40179911)
106. Hornberg JJ, Bruggeman FJ, Westerhoff HV, Lankelma J (2006) Cancer: a systems biology disease. Biosystems 83:81-90 (Pubitemid 43199809)
107. Rosenfeld S, Kapetanovic I (2008) Systems biology and cancer prevention: all options on the table. Gene Regul Syst Bio 2:307-319
108. Laubenbacher R, Hower V, Jarrah A, Torti SV, Shulaev V, Mendes P, Torti FM, Akman S (2009) A systems biology view of cancer. Biochim Biophys Acta 1796:129-139
109. Baker SG, Kramer BS (2011) Systems biology and cancer: promises and perils. Prog Biophys Mol Biol 106:410-413
110. Bizzarri M, Giuliani A, Cucina A, D'Anselmi F, Soto AM, Sonnenschein C (2011) Fractal analysis in a systems biology approach to cancer. Semin Cancer Biol 21:175-182
111. Gentles AJ, Gallahan D (2011) Systems biology: confronting the complexity of cancer. Cancer Res 71:5961-5964
112. Price ND, Foltz G, Madan A, Hood L, Tian Q (2008) Systems biology and cancer stem cells. J Cell Mol Med 12:97-110
113. Faratian D, Goltsov A, Lebedeva G, Sorokin A, Moodie S, Mullen P, Kay C, Um IH, Langdon S, Goryanin I, Harrison DJ (2009) Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab. Cancer Res 69:6713-6720
114. Goldberger NE, Hunter KW (2009) A systems biology approach to defining metastatic biomarkers and signaling pathways. Wiley Interdiscip Rev Syst Biol Med 1:89-96
115. Enderling H, Hahnfeldt P, Hlatky L, Almog N (2012) Systems biology of tumor dormancy: linking biology and mathematics on multiple scales to improve cancer therapy. Cancer Res
116. Garnett MJ, Edelman EJ, Heidorn SJ, Greenman CD, Dastur A, Lau KW, Greninger P, Thompson IR, Luo X, Soares J, Liu Q, Iorio F, Surdez D, Chen L, Milano RJ, Bignell GR, Tam AT, Davies H, Stevenson JA, Barthorpe S, Lutz SR, Kogera F, Lawrence K, McLaren-Douglas A, Mitropoulos X, Mironenko T, Thi H, Richardson L, Zhou W, Jewitt F, Zhang T, O'Brien P, Boisvert JL, Price S, Hur W, Yang W, Deng X, Butler A, Choi HG, Chang JW, Baselga J, Stamenkovic I, Engelman JA, Sharma SV, Delattre O, Saez-Rodriguez J, Gray NS, Settleman J, Futreal PA, Haber DA, Stratton MR, Ramaswamy S, McDermott U, Benes CH (2012) Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483:570-575
117. Wang E, Lenferink A, O'Connor-McCourt M (2007) Cancer systems biology: exploring cancer-associated genes on cellular networks. Cell Mol Life Sci 64:1752-1762 (Pubitemid 47093012)
118. Kreeger PK, Lauffenburger DA (2010) Cancer systems biology: a network modeling perspective. Carcinogenesis 31:2-8
119. Cui Q, Ma Y, Jaramillo M, Bari H, Awan A, Yang S, Zhang S, Liu L, Lu M, O'Connor-McCourt M, Purisima EO, Wang E (2007) A map of human cancer signaling. Mol Syst Biol 3:152
120. Flores RJ, Li Y, Yu A, Shen J, Rao PH, Lau SS, Vannucci M, Lau CC, Man TK (2012) A systems biology approach reveals common metastatic pathways in osteosarcoma. BMC Syst Biol 6:50
121. Li J, Lenferink AE, Deng Y, Collins C, Cui Q, Purisima EO, O'Connor-McCourt MD, Wang E (2010) Identification of high-quality cancer prognostic markers and metastasis network modules. Nat Commun 1:34
122. Winter C, Kristiansen G, Kersting S, Roy J, Aust D, Knosel T, Rummele P, Jahnke B, Hentrich V, Ruckert F, Niedergethmann M, Weichert W, Bahra M, Schlitt HJ, Settmacher U, Friess H, Buchler M, Saeger HD, Schroeder M, Pilarsky C, Grutzmann R (2012) Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes. PLoS Comput Biol 8:e1002511
123. Camacho DF, Pienta KJ (2012) Disrupting the networks of cancer. Clin Cancer Res 18:2801-2808
124. Lee MJ, Ye AS, Gardino AK, Heijink AM, Sorger PK, Macbeath G, Yaffe MB (2012) Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell 149:780-794
125. Erler JT, Linding R (2012) Network medicine strikes a blow against breast cancer. Cell 149:731-733
126. Nevins JR, Potti A (2007) Mining gene expression profiles: expression signatures as cancer phenotypes. Nat Rev Genet 8:601-609 (Pubitemid 47077277)
127. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274 (Pubitemid 44571966)
128. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chan WK, Li HN, Liu CC, Singh S, Chen WJ, Chen JJ, Yang PC (2007) A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 356:11-20 (Pubitemid 46041749)
129. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801-1806
130. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812
131. Pawson T, Linding R (2008) Network medicine. FEBS Lett 582:1266-1270
132. Antman E, Weiss S, Loscalzo J (2012) Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine. Wiley Interdiscip Rev Syst Biol Med 4:367-383
133. Barabasi AL (2007) Network medicine-from obesity to the "diseasome". N Engl J Med 357:404-407
134. Zanzoni A, Soler-Lopez M, Aloy P (2009) A network medicine approach to human disease. FEBS Lett 583:1759-1765
135. Ghosh S, Basu A (2012) Network medicine in drug design: implications for neuroinflammation. Drug Discov Today 17:600-607
136. Loscalzo J, Barabasi AL (2011) Systems biology and the future of medicine. Wiley Interdiscip Rev Syst Biol Med 3:619-627
137. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL (2007) The human disease network. Proc Natl Acad Sci USA 104:8685-8690 (Pubitemid 47175372)
138. Lee DS, Park J, Kay KA, Christakis NA, Oltvai ZN, Barabasi AL (2008) The implications of human metabolic network topology for disease comorbidity. Proc Natl Acad Sci USA 105:9880-9885
139. Hidalgo CA, Blumm N, Barabasi AL, Christakis NA (2009) A dynamic network approach for the study of human phenotypes. PLoS Comput Biol 5:e1000353
140. Zhang M, Zhu C, Jacomy A, Lu LJ, Jegga AG (2011) The orphan disease networks. Am J Hum Genet 88:755-766
141. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70 (Pubitemid 30046295)
142. Karr JR, Sanghvi JC, Macklin DN, Gutschow MV, Jacobs JM, Bolivar B Jr, Assad-García N, Glass JI, Covert MW (2012) A whole-cell computational model predicts phenotype from genotype. Cell 150:389-401
143. Freddolino PL, Tavazoie S (2012) The dawn of virtual cell biology. Cell 150:248-250